Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 4
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Sodium Salicyl 80 % WSP 800 mg/g V/MRP/11/0057 Dopharma Research B.V., Nīderlande QN02BA04 cattle (calf); pigs Vairāk

Medicinal product information

Pharmaceutical form: powder for oral solution
International name (active substance): Sodium salicylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 02-Oct-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 300322LI (30-Mar-2022)
Labelling text: [DOCX] 300322M (30-Mar-2022)
Summary of product characteristics: [DOCX] 300322ZA (30-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0057-01 800 mg/g 1 Polietilēna spainis, 1 kg -
V/MRP/11/0057-02 800 mg/g 1 Polietilēna spainis, 2,5 kg -
V/MRP/11/0057-03 800 mg/g 1 Polietilēna spainis, 5 kg -
V/MRP/11/0057-04 800 mg 1 Polipropilēna konteiners, 1 kg -
V/MRP/11/0057-05 800 mg/g 1 Kanna, 1 kg -
BioEquin H - V/MRP/15/0056 Bioveta, a.s., Čehija QI05AA05 horses Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated equine herpes virus type 1
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 30-Jan-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 160523LI (16-May-2023)
Labelling text: [PDF] 310119M (31-Jan-2019)
Summary of product characteristics: [DOCX] 160523ZA (16-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0056-01 2 Stikla flakons, 1 deva -
V/MRP/15/0056-02 5 Stikla flakons, 1 deva -
V/MRP/15/0056-03 10 Stikla flakons, 1 deva -
V/MRP/15/0056-04 1 Stikla flakons, 5 deva -
V/MRP/15/0056-05 10 Stikla flakons, 5 deva -
HIPRAGUMBORO GM97 - V/MRP/18/0034 Laboratorios Hipra S.A., Spānija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oral suspension
International name (active substance): Live Infectious bursitis virus, strain GM97
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 02-Jan-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0034-01 1 Stikla flakons, 1000 deva -
V/MRP/18/0034-02 1 Stikla flakons, 5000 deva -
V/MRP/18/0034-03 10 Stikla flakons, 1000 deva -
V/MRP/18/0034-04 10 Stikla flakons, 5000 deva -
Caninsulin vet. 40 IU/ml V/MRP/13/0021 Intervet International B.V., Nīderlande QA10AC03 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Porcine insulin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International GmbH, Vācija
Date of authorisation/renewal: 27-Oct-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Sep-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0021-01 40 IU/ml 10 Stikla flakons, 2,5 ml -
V/MRP/13/0021-02 40 IU/ml 10 Stikla flakons, 10 ml -
V/MRP/13/0021-03 40 IU/ml 10 Stikla kārtridžs, 2,7 ml -
Censulfatrim 200 mg/ml + 40 mg/ml - V/MRP/23/0008 Cenavisa S.L, Spānija QJ01EW10 cattle; pigs; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Sulfadiazine, Trimethoprim
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 28-Mar-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/23/0008-01 1 Stikla flakons, 100 ml -
V/MRP/23/0008-02 1 Stikla flakons, 250 ml -
V/MRP/23/0008-03 10 Stikla flakons, 100 ml -
V/MRP/23/0008-04 10 Stikla flakons, 250 ml -
MULTIMIN - V/MRP/21/0020 Warburton Technology Limited, Īrija QA12CX99 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Zinc oxide, Manganese carbonate, Sodium selenite, COPPER(II) CARBONATE
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratoires Biove, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0020-01 1 PET flakons, 100 ml -
V/MRP/21/0020-02 1 PET flakons, 500 ml -
Cepetor 1 mg/ml V/MRP/07/1685 CP-Pharma Handelsgesellschaft GmbH, Vācija QN05CM91 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Medetomidine hydrohloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP Pharma GmbH, Vācija
Date of authorisation/renewal: 16-Dec-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (07-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1685-01 1 mg/ml 1 Stikla pudelīte, 10 ml -
V/MRP/07/1685-02 1 mg/ml 5 Stikla pudelīte, 10 ml -
Prednisolonacetat-Injektionssuspension 10 mg/ml V/NRP/95/0123 AS Dimedium Latvija, Latvija QH02AB06 cattle; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Prednisolone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 21-May-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 18122020LI (18-Dec-2020)
Labelling text: [DOCX] 18122020M (18-Dec-2020)
Summary of product characteristics: [DOCX] 18122020ZA (18-Dec-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0123-01 10 mg/ml 1 Flakons, 100 ml -
V/NRP/95/0123-02 10 mg/ml 12 Flakons, 100 ml -
Nobilis Gumboro 228E - V/NRP/95/0176 Intervet International B.V., Nīderlande QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Infectious bursal disease virus, strain LZD 228E, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0176-01 10 Stikla flakons, 1000 deva -
V/NRP/95/0176-02 10 Stikla flakons, 2500 deva -
V/NRP/95/0176-03 10 Stikla flakons, 5000 deva -
V/NRP/95/0176-04 12 Kausiņš, 1000 deva -
V/NRP/95/0176-05 12 Kausiņš, 2500 deva -
V/NRP/95/0176-06 12 Kausiņš, 5000 deva -
V/NRP/95/0176-07 12 Kausiņš, 10000 deva -
V/NRP/95/0176-08 6 Kausiņš, 10000 deva -
Spizobactin vet 750000 IU/125 mg - V/DCP/17/0037 Le Vet Beheer B.V., Nīderlande QJ01RA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Spiramycin, Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 27-Sep-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0037-01 1 Blisteris, 10 tablete -
V/DCP/17/0037-02 2 Blisteris, 10 tablete -
V/DCP/17/0037-03 3 Blisteris, 10 tablete -
V/DCP/17/0037-04 10 Kastīte ar blisteri, 10 tablete -
V/DCP/17/0037-05 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
Spizobactin vet 1500000 IU/250 mg - V/DCP/17/0038 Le Vet Beheer B.V., Nīderlande QJ01RA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Spiramycin, Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 27-Sep-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0038-01 1 Blisteris, 10 tablete -
V/DCP/17/0038-02 2 Blisteris, 10 tablete -
V/DCP/17/0038-03 3 Blisteris, 10 tablete -
V/DCP/17/0038-04 10 Kastīte ar blisteri, 10 tablete -
V/DCP/17/0038-05 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
Spizobactin vet 3000000 IU/500 mg - V/DCP/17/0039 Le Vet Beheer B.V., Nīderlande QJ01RA04 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Spiramycin, Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 27-Sep-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0039-01 1 Blisteris, 10 tablete -
V/DCP/17/0039-02 2 Blisteris, 10 tablete -
V/DCP/17/0039-03 3 Blisteris, 10 tablete -
V/DCP/17/0039-04 10 Kastīte ar blisteri, 10 tablete -
V/DCP/17/0039-05 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
Clindabactin 55 mg V/DCP/19/0025 Dechra Regulatory B.V., Nīderlande QJ01FF01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Clindamycin (as Clindamycin hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0025-01 55 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-02 55 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-03 55 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-04 55 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-05 55 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-06 55 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-07 55 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-08 55 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-09 55 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-10 55 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-11 55 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0025-12 55 mg 10 Kastīte ar Al/OPA/Al/PVH blisteri, 10 tablete -
Clindabactin 220 mg V/DCP/19/0026 Dechra Regulatory B.V., Nīderlande QJ01FF01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Clindamycin (as Clindamycin hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0026-01 220 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-02 220 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-03 220 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-04 220 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-05 220 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-06 220 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-07 220 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-08 220 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-09 220 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-10 220 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-11 220 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0026-12 220 mg 10 Kastīte ar Al/OPA/Al/PVH blisteri, 10 tablete -
Clindabactin 440 mg V/DCP/19/0027 Dechra Regulatory B.V., Nīderlande QJ01FF01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Clindamycin (as Clindamycin hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0027-01 440 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-02 440 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-03 440 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-04 440 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-05 440 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-06 440 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-07 440 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-08 440 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-09 440 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-10 440 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-11 440 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0027-12 440 mg 10 Kastīte ar Al/OPA/Al/PVH blisteri, 10 tablete -
Alfaxan Multidose 10 mg/ml V/MRP/21/0071 Zoetis Belgium S.A., Beļģija QN01AX05 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Alfaxalone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0071-01 1 Stikla flakons, 10 ml -
V/MRP/21/0071-02 1 Stikla flakons, 20 ml -
Milpro 12,5 mg/125 mg - V/MRP/20/0028 VIRBAC, Francija QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/20/0028-01 12,5 mg/125 mg 1 Al/Al blisteris, 2 tablete -
V/MRP/20/0028-02 12,5 mg/125 mg 2 Al/Al blisteris, 2 tablete -
V/MRP/20/0028-03 12,5 mg/125 mg 12 Al/Al blisteris, 2 tablete -
V/MRP/20/0028-04 12,5 mg/125 mg 24 Al/Al blisteris, 2 tablete -
Vetbromide 600 mg V/DCP/21/0011 DOMES PHARMA, Francija QN03AX91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets for oral use
International name (active substance): Potassium bromide
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Europhartech, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0011-01 600 mg 4 Blisteris, 15 tablete -
V/DCP/21/0011-02 600 mg 8 Blisteris, 15 tablete -
EVOCTIN PLUS 10 mg/ml + 100 mg/ml - V/DCP/25/0021 Adoh B.V., Nīderlande QP54AA51 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin, Clorsulon
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pasteur Filiala Pilipesti S.A., Rumānija
Date of authorisation/renewal: 01-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0021-01 1 Stikla pudele (brūna), 100 ml -
V/DCP/25/0021-02 1 Stikla pudele (brūna), 250 ml -
V/DCP/25/0021-03 1 Stikla pudele (brūna), 500 ml -
Marbofloxacin Bioveta 100 mg/ml V/DCP/25/0022 Bioveta, a.s., Čehija QJ01MA93 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 01-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0022-01 1 Stikla flakons, 100 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy